A study to compare pomegranate fruit peel powder converted into gel and commercially available gel in the treatment of disease called oral lichen planus

Efficacy of PUNICA GRANATUM peel extract in the treatment of ORAL LICHEN PLANUS in comparison with TRIAMCINOLONE ACETONIDE 0.1%

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016523

Enrollment

Registered

2018-12-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D898- Other specified disorders involving the immune mechanism, not elsewhere classified

Interventions

Intervention1: Punica granatum : Punica granatum peel extract gel - 1gm of gel thrice a day for 7 days Control Intervention1: TESS ORABASE: TRIAMCINOLONE ACETONIDE 0.1%- 1gm of gel thrice a day for 7

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed clinically and histopathologically with symptomatic reticular and erosive lichen planus.

Exclusion criteria

Exclusion criteria: 1.Patients who are under steroids at the time of treatment or in last three months. 2.Patients on treatment regimens such as chemotherapy and radiation therapy 3.Patients with uncontrolled systemic illness. 4.Patients who are not willing for the treatment.

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of Punica granatum peel extract in the treatment of oral lichen planus when compared with Triamcinolone acetonide 0.1%.Timepoint: 2 MONTHS	—

Secondary

Measure	Time frame
Patient complianceTimepoint: 2 Months	—

Countries

India

Contacts

Public ContactDr Jyothirmai

Vishnu Dental College

jyothirmaik2006@gmail.com9866432477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026